Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome

Abstract
Although health disparities in women presenting with acute coronary syndrome (ACS) have received growing attention in recent years, clinical outcomes from ACS are still worse for women than for men. Women continue to experience higher patient and system delays and receive less aggressive invasive treatment and pharmacotherapies. Gender- and sex-specific variables that contribute to ACS vulner-ability remain largely unknown. Not with standing the sex differences in baseline coronary anatomy and function, women and men are treated the same based on guidelines that were established from experimental and clinical trial data over-representing the male population. Importantly, younger women have a particularly unfavourable prognosis and a plethora of unanswered questions remains in this younger population. The present review summarizes contemporary evidence for gender and sex differences in vascular biology, clinical presentation, and outcomes of ACS . We further discuss potential mechanisms and non-traditional risk conditions modulating the course of disease in women and men, such as unrecognized psycho social factors, sex-specific vascular and neural stress responses, and the potential impact of epigenetic modifications.
Funding Information
  • Swiss National Science Foundation
  • SNSF
  • Olga Mayenfisch Foundation
  • OPO Foundation
  • Novartis Foundation
  • Swiss Heart Foundation
  • Helmut Horten Foundation
  • EMDO Foundation